GSA Capital Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
2025
Q1
Sell
2024
Q4
$65K Buy
2024
Q3
$351K Buy
2024
Q2
$324K Buy
2024
Q1
$480K Sell
2023
Q4
$764K Sell
2023
Q3
$586K Sell
2023
Q2
$668K Buy
2023
Q1
$141K Sell
2022
Q4
$428K Buy
2022
Q1
Sell
2021
Q4
$393K Buy